BIO vs SPIR · rev $2.58B vs rev $110.5M
BIO (BIO) versus Spire Global Inc (SPIR) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Spire Global Inc (SPIR) is a specialty business services company listed on US.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported SPIR revenue for 2024-12-31 was $110.5M. Net income was -$102.8M. Revenue was up 13.2% from 2023-12-31 to 2024-12-31. SPIR currently screens at market cap $351.2M.
BIO currently screens at market cap $0. SPIR currently screens at market cap $351.2M.
Not investment advice. Open the BIO and SPIR stock pages for the full models.
Not investment advice.